-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bcs641zZtRnQhqj1Q26cVFH3XeJU55blmxblavbakfOFAcGesqNLjk9urX6hee2+ yQc5pH2zh2j/S4s2fJzPQQ== 0001324517-06-000027.txt : 20060425 0001324517-06-000027.hdr.sgml : 20060425 20060425124140 ACCESSION NUMBER: 0001324517-06-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060421 FILED AS OF DATE: 20060425 DATE AS OF CHANGE: 20060425 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lasowski Juergen CENTRAL INDEX KEY: 0001360376 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 06777265 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-04-21 0000890465 NPS PHARMACEUTICALS INC NPSP 0001360376 Lasowski Juergen 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 1 0 0 Senior VP Business Development Stock Option 8.61 2006-04-21 4 A 0 71000 0 A 2007-04-21 2016-04-21 Common Stock 71000 71000 D Stock option granted under the 2005 Omnibus Incentive Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter. Kevin J. Ontiveros 2006-04-24 -----END PRIVACY-ENHANCED MESSAGE-----